Medical Journals

Matrix Metalloproteases from Chondrocytes Generate an Antiangiogenic 16 Kda Prolactin.

Authors:
  • Macotela Yazmín
  • Aguilar Manuel B
  • Guzmán-Morales Jessica
  • Rivera José C
  • Zermeño Consuelo
  • López-Barrera Fernando
  • Nava Gabriel
  • Lavalle Carlos
  • Martínez de la Escalera Gonzalo
  • Clapp Carmen

From: Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México.

Journal of cell science

  • Publish Date: May 2006
  • ISSN: 0021-9533
  • Volume: 119
  • Issue: Pt 9
  • Pages: 1790-800
  • Medium: Print
  • Language: English
  • Citation (JAMA): Macotela Yazmín, Aguilar Manuel B, Guzmán-Morales Jessica, et al. Matrix Metalloproteases from Chondrocytes Generate an Antiangiogenic 16 Kda Prolactin.. J. Cell. Sci. May 2006;119:1790-800

Abstract

The 16 kDa N-terminal fragment of prolactin (16K-prolactin) is a potent antiangiogenic factor. Here, we demonstrate that matrix metalloproteases (MMPs) produced and secreted by chondrocytes generate biologically functional 16K-prolactin from full-length prolactin. When incubated with human prolactin at neutral pH, chondrocyte extracts and conditioned medium, as well as chondrocytes in culture, cleaved the Ser155-Leu156 peptide bond in prolactin, yielding - upon reduction of intramolecular disulfide bonds - a 16 kDa N-terminal fragment. This 16K-prolactin inhibited basic fibroblast growth factor (FGF)-induced endothelial cell proliferation in vitro. The Ser155-Leu156 site is highly conserved, and both human and rat prolactin were cleaved at this site by chondrocytes from either species. Conversion of prolactin to 16K-prolactin by chondrocyte lysates was completely abolished by the MMP inhibitors EDTA, GM6001 or 1,10-phenanthroline. Purified MMP-1, MMP-2, MMP-3, MMP-8, MMP-9 and MMP-13 cleaved human prolactin at Gln157, one residue downstream from the chondrocyte protease cleavage site, with the following relative potency: MMP-8 > MMP-13 > MMP-3 > MMP-1= MMP-2 > MMP-9. Finally, chondrocytes expressed prolactin mRNA (as revealed by RT-PCR) and they contained and released antiangiogenic N-terminal 16 kDa prolactin (detected by western blot and endothelial cell proliferation). These results suggest that several matrix metalloproteases in cartilage generate antiangiogenic 16K-prolactin from systemically derived or locally produced prolactin.

Mesh Headings (Keywords): Amino Acid Sequence, Angiogenesis Inhibitors, Animals, Cells, Cultured, Chondrocytes, Culture Media, Conditioned, Humans, Male, Matrix Metalloproteinases, Molecular Sequence Data, Molecular Weight, Peptide Fragments, Prolactin, RNA, Messenger, Rats, Rats, Wistar


Check for Full Text / PubMed Unique Identifier (PMID): 16608881


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.